Vistin Pharma - Call Transcript 2022

Vistin Pharma ASA: Invitation to Q2 2022 conference call

Oslo, Norway, 11 August 2022

Vistin Pharma ASA will release its second quarter and YTD 2022 results on

Friday 19(th) of August 2022. Vistin Pharma will host a conference call for all

shareholders and interested parties at the same day; Friday 19(th) of August at

08:30 CET. There will be a Q&A session following the management discussion.

The conference call will be held in English.

The second quarter conference call will be available via webcast and audio

through the following access points:

Webcast:

https://edge.media-server.com/mmc/p/m83myj4s

Telephone conference (online registration):

https://register.vevent.com/register/BI3e5ac1165d974dacab56dd8f81b4fba4

*****

For further information, please contact:

Alexander Karlsen

CFO

+47 97053621

About Vistin Pharma | www.vistin.com

Vistin Pharma is a Norwegian pharmaceutical company producing Metformin

Hydrochloride (API). The Metformin is also available as Direct Compressible

lubricated granules. As a solely dedicated European Metformin producer, Vistin

Pharma is a well-positioned supplier to leading pharmaceutical companies. Vistin

Pharma is headquartered in Oslo, Norway, and has highly qualified employees and

a dedicated manufacturing facility in Kragerø.

AI assistant